eye, with Scer\GAL4ey.PB
eye, with Scer\GAL4GMR.PF
eye, with Scer\GAL4GMR.PU
eye photoreceptor cell & neuron, with Scer\GAL4hs.2sev
The expression of Hsap\MAPTR406W.UAS under the control of Scer\GAL4GMR.PU induces a rough eye phenotype.
10-day old adults expressing Hsap\MAPTR406W.UAS under the control of Scer\GAL4elav-C155 show elevated apoptosis in the brain.
Expression of Hsap\MAPTR406W.UAS under the control of Scer\GAL4elav.PU increases apoptosis (TUNEL) in the adult brain, compared to controls.
Expression of Hsap\MAPTR406W.Scer\UAS driven pan-neuronally by Scer\GAL4elav-C155 leads to a significantly shortened lifespan compared to control flies and flies with expression of Hsap\MAPTV337M.Scer\UAS. Scer\GAL4elav-C155>Hsap\MAPTR406W.Scer\UAS flies show significant changes in the activity of antioxidant enzymes.
Expression of Hsap\MAPTR406W.Scer\UAS driven in mushroom bodies by Scer\GAL4c739 leads to a significant impairment in middle-term and long-term olfactory memory compared to controls.
Scer\GAL4GMR.PF-mediated expression of Hsap\MAPTR406W.Scer\UAS results in a rough eye.
Scer\GAL4elav-C155-mediated expression of Hsap\MAPTR406W.Scer\UAS results in a significant decrease in synaptic vesicles at larval neuromuscular junctions, but only minor changes in its overall appearance.
Scer\GAL4elav-C155-mediated expression of Hsap\MAPTR406W.Scer\UAS has no apparent effect on larval motor coordination or locomotion, or on eclosion rates.
Expression of Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PU results in a reduction in adult lifespan compared to controls.
Transgenic flies expressing Scer\GAL4elav.PU>Hsap\MAPTR406W.Scer\UAS show reduced locomotor activity compared with control flies.
Feeding flies ZnCl[[2]] enhances the toxicity seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4elav.PU, further reducing lifespan. Feeding the flies CQ (a hydrophobic metal chelator) partially rescues the toxicity, elongating the lifespan. No changes in lifespan are observed when wild type flies are fed the same levels of metals.
Expression of Hsap\MAPTR406W.Scer\UAS using Scer\GAL4elav.PLu induces neuronal cell death and abnormal cell cycle reactivation. The transgenic flies expressing Hsap\MAPTR406W.Scer\UAS display locomotor defect as assayed by measuring walking speed.
Flies expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PU exhibit normal learning and memory in an aversive phototaxis assay at two days after eclosion. Learning and memory are both significantly reduced at 20 days post-eclosion.
Expression of Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PU results in an age-dependent decrease in locomotor activity as measured by climbing performance.
Vacuolisation is observed in the brains of 2 day old flies expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PU. By 20 days multiple large vacuoles can be observed and an increased number of apoptotic cells (caspase 3 positive) is seen in the mid brain compared to controls.
The mitochondria in the neurons of adult brains expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PU are markedly elongated. Mitochondria length is on average greater than twice that of controls. Neuron death (assayed by TUNEL staining) is also observed. An increase in cell cycle activation (assayed by PCNA) is also seen compared to controls.
The brains of animals expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PU show a significant increase in superoxide production (assayed using dihydroethidium) compared to controls.
Expression of Hsap\MAPTR406W.Scer\UAS driven by Scer\GAL4Appl.G1a induces substantial axonal vesicle accumulations in larvae and results in increased lethality during development, as compared to controls.
Neuronal expression of Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav-C155 results in reduced adult lifespan and results in adult brains presenting increases in both apoptosis {as visualised with TUNEL) and DNA replication (as visualized with PCNA) and vacuolar degeneration, compared to wild-type controls.
Pan-neuronal expression of Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PU results in severe mushroom body (MB) defects that are generally bilateral. The brain defects are restricted to the MBs.
Expression of Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav-C155 increases the level of apoptosis in the nervous system.
Flies expressing Hsap\MAPTR406W.Scer\UAS in neurons under the control of Scer\GAL4elav.PU show mushroom body aberrations.
Expression of Hsap\MAPTR406W.Scer\UAS in the developing eye under the control of Scer\GAL4GMR.PF generates a severe rough eye phenotype. The orderly ommatidial architecture is disorganized and photoreceptors are fused with missing mechanosensory bristles.
Expression of Hsap\MAPTR406W.Scer\UAS in the developing external sensory organs under the control of Scer\GAL4Eq1 generates a severe bristle loss phenotype.
Expression of Hsap\MAPTR406W.Scer\UAS using Scer\GAL4GMR.PF produces a rough and reduced eye.
Expression of Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PU results in neurodegeneration of both the cortex and neuropil in 10-day old flies, with these regions exhibiting vacuolization and an increase in neuron apoptosis, as compared to controls.
Expression of Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PLu results in increased levels of neuronal cell death.
Expression of Hsap\MAPTR406W.Scer\UAS driven by Scer\GAL4GMR.PF results in ablation of the adult eye.
Expression of Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4GMR.PF results in a rough eye phenotype and mild photoreceptor loss.
Expression of Scer\GAL4ey.PB>Hsap\MAPTR406W.Scer\UAS leads to the formation of abnormal eyes or no eyes. Rapamycin treatment ameliorates the eye phenotype.
Expression of Hsap\MAPTR406W.Scer\UAS in the developing eye (under the control of Scer\GAL4GMR.PF) induces severe neurodegeneration, reflected by a severely disrupted eye phenotype.
Adult brains from newly-eclosed animals expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PLu appear morphologically normal, but by 10 days neurodegeneration is observed, and vacuolar degeneration of the lamina is observed. Increased rates of cell division are also observed in these mutant brains.
21 day old flies expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4c492b do not exhibit obvious degeneration or vacuoles in the mushroom body. Severe neurodegeneration and large vacuoles are observed in the mushroom bodies of 60 day old flies expressing Hsap\MAPTR406W.Scer\UAS using Scer\GAL4c492b. Degenerating neurons and vacuoles are observed in the mushroom body, but not in the ellipsoid body where the Scer\GAL4c492b driver is inactive.
Flies expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4hs.2sev show a moderate eye degeneration phenotype. A 6% loss in photoreceptor neurons is seen. Expression of Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4Cha.7.4 results in mild vacuole formation in the cell bodies of the cholinergic neurons. About 13% of neurons stain positive in a TUNEL assay in clones expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4hs.2sev in the brain, significantly more than in control clones.
Expression of Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PLu results in a severe reduction in adult life span. The effect on life span is dosage sensitive. 1 day old adults has no brain abnormalities. Aged flies show neurodegeneration; vacuolisation and degeneration of cells in the cortex is seen. There is also a modest increase in neuropil vacuolisation. The degeneration is progressive and the phenotype is fully penetrant. No evidence of large filamentous aggregates (neurofibrillary tangles) is seen in the brains of adults expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PLu or Scer\GAL4Cha.7.4. Cholinergic neurons of the optic lamina appear normal in 1 day old adults expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4Cha.7.4. However, 30 day old flies show widespread vacuolization and loss of cholinergic neurons in the optic lamina. Loss of cholinergic neurons is also seen in the central body complex. 1 day old adults expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PLu have a normal number of cholinergic terminals in the brain. The number of acetylcholine-positive terminals is strongly reduced in aged flies.
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has visible | adult stage phenotype, enhanceable by rswlGD12447, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has visible | adult stage phenotype, enhanceable by scuGD1528, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has visible | adult stage phenotype, enhanceable by Trmt61GD8364, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has increased cell death | adult stage phenotype, enhanceable by Hsap\TBK1UAS.Tag:HA, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has increased cell death | adult stage phenotype, enhanceable by IKKεUAS.ORF.Tag:HA, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has increased cell death | adult stage phenotype, enhanceable by cindr1/Df(3R)Exel6217
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has increased cell death | adult stage phenotype, enhanceable by cindr1/cindr1
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has visible phenotype, enhanceable by Hsap\SOD1UAS.cWa, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has visible phenotype, enhanceable by Hsap\SOD1A4V.UAS, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal locomotor behavior phenotype, enhanceable by Hsap\SOD1UAS.cWa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype, enhanceable by Hsap\SOD1UAS.cWa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal locomotor behavior phenotype, enhanceable by Hsap\SOD1A4V.UAS, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype, enhanceable by Hsap\SOD1A4V.UAS, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has increased cell death phenotype, enhanceable by Su(var)2055/Su(var)205[+]
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal locomotor behavior phenotype, enhanceable by Su(var)2055/Su(var)205[+]
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has increased cell death phenotype, enhanceable by Su(var)205MB11439/Su(var)205[+]
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has increased cell death phenotype, enhanceable by Su(var)3-91/Su(var)3-9[+]
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has increased cell death phenotype, enhanceable by Su(var)3-9[+]/Su(var)3-92
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal locomotor behavior phenotype, enhanceable by Su(var)3-9[+]/Su(var)3-92
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has visible phenotype, enhanceable by Zip42C.1UAS.cLa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has short lived phenotype, enhanceable by Zip42C.1UAS.cLa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype, enhanceable by Zip42C.1UAS.cLa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has visible phenotype, enhanceable by ZnT63CRNAi.UAS.cWa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has short lived phenotype, enhanceable by ZnT63CRNAi.UAS.cWa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype, enhanceable by ZnT63CRNAi.UAS.cWa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has abnormal mitotic cell cycle phenotype, enhanceable by SytβDG10711, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has increased cell death phenotype, enhanceable by SytβJF02593
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has abnormal mitotic cell cycle phenotype, enhanceable by SytβJF02593
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has increased cell death phenotype, enhanceable by p5311-1B-1
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has abnormal mitotic cell cycle phenotype, enhanceable by p5311-1B-1
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has abnormal locomotor behavior phenotype, enhanceable by p5311-1B-1
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has increased cell death phenotype, enhanceable by p535A-1-4
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has abnormal mitotic cell cycle phenotype, enhanceable by p535A-1-4
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has increased cell death phenotype, enhanceable by AmphEY09339
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has abnormal mitotic cell cycle phenotype, enhanceable by AmphEY09339
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has increased cell death phenotype, enhanceable by AmphGD1311, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has abnormal mitotic cell cycle phenotype, enhanceable by AmphGD1311, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has increased cell death phenotype, enhanceable by ClcDG23206
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has abnormal mitotic cell cycle phenotype, enhanceable by ClcDG23206
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has increased cell death phenotype, enhanceable by Chc1
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has abnormal mitotic cell cycle phenotype, enhanceable by Chc1
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has increased cell death phenotype, enhanceable by Chc4
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has abnormal mitotic cell cycle phenotype, enhanceable by Chc4
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has increased cell death phenotype, enhanceable by Rab26T204N.UAS.YFP, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has abnormal mitotic cell cycle phenotype, enhanceable by Rab26T204N.UAS.YFP, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has increased cell death phenotype, enhanceable by Rab26GD9927, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has abnormal mitotic cell cycle phenotype, enhanceable by Rab26GD9927, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has increased cell death phenotype, enhanceable by SytβDG10711, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype, enhanceable by MarfUAS.cDa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal cell death phenotype, enhanceable by MarfUAS.cDa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal cell cycle phenotype, enhanceable by MarfUAS.cDa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype, enhanceable by Drp1GD10456, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal cell death phenotype, enhanceable by Drp1GD10456, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal cell cycle phenotype, enhanceable by Drp1GD10456, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype, enhanceable by Drp1T26
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal cell death phenotype, enhanceable by Drp1T26
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has visible phenotype, enhanceable by CG6873GD12062, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has visible phenotype, enhanceable by CG2887GD9842, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4Appl.G1a has partially lethal phenotype, enhanceable by Klc[+]/Klc8ex94
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has increased occurrence of cell division phenotype, enhanceable by cathD1/cathD1
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has short lived phenotype, enhanceable by cathD1
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has increased cell death phenotype, enhanceable by cathD1
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has abnormal cell cycle phenotype, enhanceable by Xbp1GD4745, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has increased cell death phenotype, enhanceable by Xbp1GD4745, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has abnormal neuroanatomy phenotype, enhanceable by Xbp1GD4745, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has increased cell death phenotype, enhanceable by Xbp1k13803
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has abnormal neuroanatomy phenotype, enhanceable by Xbp1k13803
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has abnormal neuroanatomy phenotype, enhanceable by Vha100-1GD12710, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has abnormal neurophysiology phenotype, enhanceable by Vha100-1GD12710, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has visible phenotype, enhanceable by embE2-1A, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy | adult stage phenotype, enhanceable by Trxr-1[+]/Trxr1Δ1
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has increased cell death | adult stage phenotype, enhanceable by Trxr-1[+]/Trxr1Δ1
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy | adult stage phenotype, enhanceable by Sod2n283/Sod2[+]
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has increased cell death | adult stage phenotype, enhanceable by Sod2n283/Sod2[+]
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has increased cell death phenotype, enhanceable by Act5CUAS.GFP, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has visible | adult stage phenotype, enhanceable by Hsap\APP695.T.UAS, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has visible | adult stage phenotype, enhanceable by Lkb1UAS.cWa, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has decreased cell number | adult stage phenotype, enhanceable by Lkb1UAS.cWa, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has increased cell death phenotype, enhanceable by loqsf00791, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has increased cell death | conditional phenotype, enhanceable by CycAUAS.cWa, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4hs.2sev has visible phenotype, enhanceable by par-1UAS.cSa, Scer\GAL4hs.2sev
Hsap\MAPTR406W.UAS, Scer\GAL4ChAT.7.4 has abnormal neuroanatomy phenotype, enhanceable by par-1UAS.cSa, Scer\GAL4ChAT.7.4
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has visible | adult stage phenotype, non-enhanceable by Arc1UAS.cMb, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has decreased rate of adult locomotory behavior phenotype, non-enhanceable by Arc1UAS.cMb, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has increased cell death | adult stage phenotype, non-enhanceable by Arc1UAS.cMb, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has visible | adult stage phenotype, non-enhanceable by Arc1esm113
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has visible | adult stage phenotype, non-enhanceable by Trmt6KK109131, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has visible | adult stage phenotype, non-enhanceable by mldrKK108043, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has visible | adult stage phenotype, suppressible | partially by Arc1JF01974, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has decreased rate of adult locomotory behavior phenotype, suppressible | partially by Arc1esm113
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has decreased rate of adult locomotory behavior phenotype, suppressible | partially by Arc1JF01974, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has increased cell death | adult stage phenotype, suppressible | partially by Arc1esm113
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has increased cell death | adult stage phenotype, suppressible | partially by Arc1JF01974, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has increased cell death | adult stage phenotype, suppressible by IKKεGL00160, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has short lived phenotype, suppressible by POLDIP2EY08866
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has increased cell death phenotype, suppressible by ash1B1/ash1[+]
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has increased cell death phenotype, suppressible by ash1RNAi.UAS.cUa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has increased cell death phenotype, suppressible by Nurf-38JF01299, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has increased cell death phenotype, suppressible by E(bx)JF01709, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal locomotor behavior phenotype, suppressible by ash1RNAi.UAS.cUa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal locomotor behavior phenotype, suppressible by E(bx)JF01709, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has increased cell death phenotype, suppressible by AGO3GL00117, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal locomotor behavior phenotype, suppressible by AGO3GL00117, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has increased cell death phenotype, suppressible by AGO3HMS00125, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has visible phenotype, suppressible by ZnT63CUAS.cWa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has short lived phenotype, suppressible by ZnT63CUAS.cWa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype, suppressible by ZnT63CUAS.cWa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has visible phenotype, suppressible by Zip42C.1RNAi.UAS, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has short lived phenotype, suppressible by Zip42C.1RNAi.UAS, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype, suppressible by Zip42C.1RNAi.UAS, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has increased cell death phenotype, suppressible by Rab26UAS.YFP, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has abnormal mitotic cell cycle phenotype, suppressible by Rab26UAS.YFP, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal learning | adult stage phenotype, suppressible by NmnatUAS.cZa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal memory | adult stage phenotype, suppressible by NmnatUAS.cZa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy | progressive phenotype, suppressible by NmnatUAS.cZa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has increased cell death phenotype, suppressible by NmnatUAS.cZa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal learning | adult stage phenotype, suppressible by NmnatWR.UAS.PD, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal memory | adult stage phenotype, suppressible by NmnatWR.UAS.PD, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy | progressive phenotype, suppressible by NmnatWR.UAS.PD, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has increased cell death phenotype, suppressible by NmnatWR.UAS.PD, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal locomotor behavior | adult stage | progressive phenotype, suppressible by NmnatUAS.cZa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal locomotor behavior | adult stage | progressive phenotype, suppressible by NmnatWR.UAS.PD, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype, suppressible by Drp1UAS.cDb, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal cell death phenotype, suppressible by Drp1UAS.cDb, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal cell cycle phenotype, suppressible by Drp1UAS.cDb, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype, suppressible by MarfJF01650, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal cell death phenotype, suppressible by MarfJF01650, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal cell cycle phenotype, suppressible by MarfJF01650, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype, suppressible by Opa1s3475
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal cell death phenotype, suppressible by Opa1s3475
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype, suppressible by Df(1)Exel6239
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal cell death phenotype, suppressible by Df(1)Exel6239
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has visible phenotype, suppressible by PICK1KK109273, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has visible phenotype, suppressible by CG16890GD9226, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has visible phenotype, suppressible by MRG15GD11902, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has visible phenotype, suppressible by Tpr2EB7-1A, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has visible phenotype, suppressible by CG11700EP1384, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has visible phenotype, suppressible by Acox1B227.2, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has visible phenotype, suppressible by wechJM265, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has visible phenotype, suppressible by ImpEP1433, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy | adult stage phenotype, suppressible by GtpxUAS.cMa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has increased cell death | adult stage phenotype, suppressible by GtpxUAS.cMa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy | adult stage phenotype, suppressible by Sod2UAS.cMa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has increased cell death | adult stage phenotype, suppressible by Sod2UAS.cMa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has increased cell death phenotype, suppressible by tsrUAS.Tag:polyHis, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has increased cell death | conditional phenotype, suppressible by dapUAS.cdNa/RbfUAS.cDa, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has increased cell death | conditional phenotype, suppressible by dapUAS.cdNa/Cdk1E51Q.UAS, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has increased cell death | conditional phenotype, suppressible by gigΔAkt-P.UAS.Tag:FLAG, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has visible | adult stage phenotype, non-suppressible by Arc1esm113
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has visible | adult stage phenotype, non-suppressible by Arc1UAS.cMb, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has decreased rate of adult locomotory behavior phenotype, non-suppressible by Arc1UAS.cMb, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has increased cell death | adult stage phenotype, non-suppressible by Arc1UAS.cMb, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has visible | adult stage phenotype, non-suppressible by Trmt6KK109131, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has visible | adult stage phenotype, non-suppressible by mldrKK108043, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype, non-suppressible by Drp1Tag:FLAG,Tag:CALI(TC),Tag:HA
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal cell death phenotype, non-suppressible by Drp1Tag:FLAG,Tag:CALI(TC),Tag:HA
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal neuroanatomy phenotype, non-suppressible by GelUAS.cDa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has abnormal cell death phenotype, non-suppressible by GelUAS.cDa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has visible phenotype, non-suppressible by Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU is an enhancer of abnormal neuroanatomy phenotype of MarfUAS.cDa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU is an enhancer of abnormal cell death phenotype of MarfUAS.cDa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Hsap\SNCAQUAS.cOa, Ncra\QFQF2.nSyb, Scer\GAL4elav-C155 has lethal phenotype
Cwc25GD9830, Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has lethal phenotype
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF, Trmt2aGD11081 has lethal phenotype
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF, snRNP-U1-CGD11660 has lethal phenotype
CG5986GD9900, Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has lethal phenotype
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF, fzyGD11268 has lethal phenotype
GdiGD11312, Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has lethal phenotype
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF, par-6GD4048 has lethal phenotype
Arv1GD1675, Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has lethal phenotype
DCTN1-p150GD1455, Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has partially lethal phenotype
DCTN2-p50GD13758, Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has partially lethal phenotype
Hsap\MAPTR406W.UAS, LerpGD306, Scer\GAL4GMR.PF has lethal phenotype
Dhc93ABGD11054, Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has lethal phenotype
Cwc25GD17298, Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has lethal phenotype
Hsap\MAPTR406W.UAS, Hsap\SOD1UAS.cWa, Scer\GAL4elav.PU has short lived phenotype
Hsap\MAPTR406W.UAS, Hsap\SOD1A4V.UAS, Scer\GAL4elav.PU has short lived phenotype
Hsap\MAPTR406W.UAS, Nmnatunspecified, Scer\GAL4elav.PU has abnormal learning | adult stage phenotype
Hsap\MAPTR406W.UAS, Nmnatunspecified, Scer\GAL4elav.PU has abnormal memory | adult stage phenotype
HisRSGD1599, Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has lethal phenotype
Hsap\MAPTR406W.UAS, Prosβ2GD10938, Scer\GAL4GMR.long has lethal phenotype
Hsap\MAPTR406W.UAS, Nrx-IVGD2436, Scer\GAL4GMR.long has lethal phenotype
Hsap\MAPTR406W.UAS, RpS10aGD7556, Scer\GAL4GMR.long has lethal phenotype
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long, brunGD5423 has lethal phenotype
Hsap\MAPTR406W.UAS, MED14GD4081, Scer\GAL4GMR.long has lethal phenotype
Hsap\MAPTR406W.UAS, Prp8GD6578, Scer\GAL4GMR.long has lethal phenotype
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long, UckGD229 has lethal phenotype
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long, vncGD7454 has lethal phenotype
Hsap\MAPTR406W.UAS, Nelf-EGD9903, Scer\GAL4GMR.long has lethal phenotype
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long, bicGD5037 has lethal phenotype
Hsap\MAPTR406W.UAS, Rab30GD14116, Scer\GAL4GMR.long has lethal phenotype
Ciz1GD12382, Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has lethal phenotype
CG8086GD12374, Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has lethal phenotype
Hsap\MAPTR406W.UAS, Rpn9GD6909, Scer\GAL4GMR.long has lethal phenotype
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long, Sf3b5GD12979 has lethal phenotype
CycJGD6936, Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has lethal phenotype
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has eye phenotype, enhanceable by rswlGD12447, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has eye phenotype, enhanceable by scuGD1528, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has eye phenotype, enhanceable by Trmt61GD8364, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has adult brain phenotype, enhanceable by Hsap\TBK1UAS.Tag:HA, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has adult brain phenotype, enhanceable by IKKεUAS.ORF.Tag:HA, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has adult brain phenotype, enhanceable by cindr1/Df(3R)Exel6217
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has adult brain phenotype, enhanceable by cindr1/cindr1
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by DCTN1-p150GD1455, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by DCTN2-p50GD13758, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by αTub84BGD9679, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by αTub84BGD17779, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by αTub67CGD13885, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by ScampGD3371, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by gGD7158, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by EloBGD4863, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by SppGD786, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by Prosα7GD3491, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by Nedd8GD12964, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by Fer1GD13372, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by CG10979GD7154, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by CG17327GD9348, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by HipkGD9283, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by DrakGD9422, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by CG6330GD11891, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by Su(z)2GD16388, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by Su(z)2GD4494, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by Flo2GD7328, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by CG7896GD20, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by CG7896GD14469, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by CG7896GD2516, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by CG8664GD3411, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by SnpGD11912, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by SnpGD10043, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by DatpGD15139, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by Vha16-1GD4523, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by Vha16-1GD17431, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by Vha36-1GD17846, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by krzGD8470, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by DabGD4886, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by T3dhGD10964, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by T3dhGD16513, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by CG3500GD2177, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by GstS1GD16335, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by GabatGD12238, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by Cyp301a1GD13977, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by ttvGD1993, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by CG8785GD1961, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by Usp10GD5121, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by DCTN4-p62GD7465, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by DCTN5-p25GD3469, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by Arp10GD7542, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by Lamtor1GD12840, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has eye phenotype, enhanceable by Hsap\SOD1UAS.cWa, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has ommatidium phenotype, enhanceable by Hsap\SOD1A4V.UAS, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has brain phenotype, enhanceable by Hsap\SOD1UAS.cWa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has neuron phenotype, enhanceable by Hsap\SOD1UAS.cWa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has brain phenotype, enhanceable by Hsap\SOD1A4V.UAS, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has neuron phenotype, enhanceable by Hsap\SOD1A4V.UAS, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has neuron phenotype, enhanceable by Su(var)2055/Su(var)205[+]
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has neuron phenotype, enhanceable by Su(var)205MB11439/Su(var)205[+]
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has neuron phenotype, enhanceable by Su(var)3-91/Su(var)3-9[+]
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has neuron phenotype, enhanceable by Su(var)3-9[+]/Su(var)3-92
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has eye phenotype, enhanceable by ZnT63CUAS.cWa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has eye phenotype, enhanceable by Zip42C.1UAS.cLa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has brain phenotype, enhanceable by p5311-1B-1
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has brain phenotype, enhanceable by p535A-1-4
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has adult brain phenotype, enhanceable by MarfUAS.cDa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has mitochondrion phenotype, enhanceable by MarfUAS.cDa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has adult brain phenotype, enhanceable by Drp1GD10456, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has mitochondrion phenotype, enhanceable by Drp1GD10456, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has adult brain phenotype, enhanceable by Drp1T26
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has mitochondrion phenotype, enhanceable by Drp1T26
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has adult brain phenotype, enhanceable by WASpUAS.cBa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has mitochondrion phenotype, enhanceable by WASpUAS.cBa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has adult brain phenotype, enhanceable by f+t13
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has mitochondrion phenotype, enhanceable by f+t13
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has adult brain phenotype, enhanceable by zip[+]/zip1
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has mitochondrion phenotype, enhanceable by zip[+]/zip1
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has adult brain phenotype, enhanceable by sqhAX3/sqh[+]
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has mitochondrion phenotype, enhanceable by sqhAX3/sqh[+]
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, enhanceable by CG6873GD12062, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, enhanceable by CG2887GD9842, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has adult brain phenotype, enhanceable by cathD1/cathD1
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has neuron | adult stage phenotype, enhanceable by cathD1/cathD1
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has photoreceptor neuron phenotype, enhanceable by Vha100-1GD12710, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has eye phenotype, enhanceable by embE2-1A, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has adult brain cell body rind phenotype, enhanceable by Trxr-1[+]/Trxr1Δ1
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has neuropil | adult stage phenotype, enhanceable by Trxr-1[+]/Trxr1Δ1
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has neuron | adult stage phenotype, enhanceable by Trxr-1[+]/Trxr1Δ1
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has adult brain cell body rind phenotype, enhanceable by Sod2n283/Sod2[+]
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has neuropil | adult stage phenotype, enhanceable by Sod2n283/Sod2[+]
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has neuron | adult stage phenotype, enhanceable by Sod2n283/Sod2[+]
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by Hsap\APP695.T.UAS, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by Lkb1UAS.cWa, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has photoreceptor phenotype, enhanceable by Lkb1UAS.cWa, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by loqsf00791, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has retina phenotype, enhanceable by loqsf00791, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has adult brain | conditional phenotype, enhanceable by CycAUAS.cWa, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has lamina | conditional phenotype, enhanceable by CycAUAS.cWa, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4hs.2sev has eye phenotype, enhanceable by par-1UAS.cSa, Scer\GAL4hs.2sev
Hsap\MAPTR406W.UAS, Scer\GAL4hs.2sev has eye photoreceptor cell & neuron phenotype, enhanceable by par-1UAS.cSa, Scer\GAL4hs.2sev
Hsap\MAPTR406W.UAS, Scer\GAL4ChAT.7.4 has neuron phenotype, enhanceable by par-1UAS.cSa, Scer\GAL4ChAT.7.4
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has eye phenotype, non-enhanceable by Arc1UAS.cMb, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has adult CNS neuron | decreased number phenotype, non-enhanceable by Arc1UAS.cMb, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has eye phenotype, non-enhanceable by Arc1esm113
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by Trmt6KK109131, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by mldrKK108043, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has neuromuscular junction | larval stage phenotype, non-enhanceable by DCTN2-p50GD13758, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, non-enhanceable by Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, non-enhanceable by lncRNA:HsrωEP3037, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, non-enhanceable by lncRNA:HsrωEP93D, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has eye phenotype, suppressible | partially by Arc1JF01974, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has adult CNS neuron | decreased number phenotype, suppressible | partially by Arc1esm113
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has adult CNS neuron | decreased number phenotype, suppressible | partially by Arc1JF01974, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has adult brain phenotype, suppressible by IKKεGL00160, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by CG42788GD8865, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by CG18508GD6805, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by nordGD5955, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by Mad1GD9715, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by ShrmGD16363, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by ShrmGD13983, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by CG31259GD2862, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by CG5500GD4790, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by hepGD1461, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by CG6418GD11919, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by smashGD10286, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by S-Lap2GD10864, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by S-Lap2GD16773, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by CG14621GD3713, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by Nuf2GD14063, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by TetGD9718, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by TetGD14834, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by TetGD14330, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by CG32809GD11076, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by CG32809GD11060, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by CG3511GD11160, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by CG15629GD890, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, suppressible by CG15629GD17179, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has neuron phenotype, suppressible by ash1B1/ash1[+]
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has neuron phenotype, suppressible by ash1RNAi.UAS.cUa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has neuron phenotype, suppressible by Nurf-38JF01299, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has neuron phenotype, suppressible by E(bx)JF01709, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has neuron phenotype, suppressible by AGO3GL00117, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has neuron phenotype, suppressible by AGO3HMS00125, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has eye phenotype, suppressible by ZnT63CUAS.cWa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has eye phenotype, suppressible by Zip42C.1RNAi.UAS, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has brain phenotype, suppressible by NmnatUAS.cZa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has brain phenotype, suppressible by NmnatWR.UAS.PD, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has adult brain phenotype, suppressible by Opa1s3475
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has mitochondrion phenotype, suppressible by Opa1s3475
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has adult brain phenotype, suppressible by Df(1)Exel6239
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has mitochondrion phenotype, suppressible by Df(1)Exel6239
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has adult brain phenotype, suppressible by GelUAS.cDa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has mitochondrion phenotype, suppressible by GelUAS.cDa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has adult brain phenotype, suppressible by Drp1UAS.cDb, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has mitochondrion phenotype, suppressible by Drp1UAS.cDb, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has adult brain phenotype, suppressible by MarfJF01650, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has mitochondrion phenotype, suppressible by MarfJF01650, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has eye phenotype, suppressible by PICK1KK109273, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by CG16890GD9226, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by MRG15GD11902, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by EloAGD1290, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by ppk14GD947, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by bwaGD3476, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by CG17048GD3783, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by Mal-A1GD5459, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by Polr2IGD4234, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by auxGD7187, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by trbdGD14218, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by 5PtaseIGD8685, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by Hsc70-4GD11264, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by Hsc70-4GD16584, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by Gβ13FGD7011, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by CG5687GD2255, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by Scer\GAL4GMR.long/Trmt2aGD11081
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by Herc4GD2240, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by Usp2GD5229, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by THADAGD9074, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by Prim1GD4566, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by Hsc70-1GD13532, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by CG17919GD17025, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by Cad88CGD2653, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by DabGD4886, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by Hrb27CGD6964, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by DoaGD8588, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by LanB1GD13179, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by Droj2GD14050, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by roqGD9209, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by IshaGD11266, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by Stip1GD9818, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.long has eye phenotype, suppressible by Fbxo42GD12027, Scer\GAL4GMR.long
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has eye phenotype, suppressible by Tpr2EB7-1A, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has eye phenotype, suppressible by CG11700EP1384, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has eye phenotype, suppressible by Acox1B227.2, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has eye phenotype, suppressible by wechJM265, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has eye phenotype, suppressible by ImpEP1433, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has adult brain cell body rind phenotype, suppressible by GtpxUAS.cMa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has neuropil | adult stage phenotype, suppressible by GtpxUAS.cMa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has neuron | adult stage phenotype, suppressible by GtpxUAS.cMa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has adult brain cell body rind phenotype, suppressible by Sod2UAS.cMa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has neuropil | adult stage phenotype, suppressible by Sod2UAS.cMa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has neuron | adult stage phenotype, suppressible by Sod2UAS.cMa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has adult brain | conditional phenotype, suppressible by dapUAS.cdNa/RbfUAS.cDa, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has lamina | conditional phenotype, suppressible by dapUAS.cdNa/RbfUAS.cDa, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PLu has adult brain | conditional phenotype, suppressible by dapUAS.cdNa/Cdk1E51Q.UAS, Scer\GAL4elav.PLu
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has eye phenotype, non-suppressible by Arc1UAS.cMb, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has eye phenotype, non-suppressible by Arc1esm113
Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has adult CNS neuron | decreased number phenotype, non-suppressible by Arc1UAS.cMb, Scer\GAL4elav-C155
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by Trmt6KK109131, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by mldrKK108043, Scer\GAL4GMR.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has mitochondrion phenotype, non-suppressible by Drp1Tag:FLAG,Tag:CALI(TC),Tag:HA
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has adult brain phenotype, non-suppressible by milt92
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has mitochondrion phenotype, non-suppressible by milt92
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU has adult brain phenotype, non-suppressible by Drp1Tag:FLAG,Tag:CALI(TC),Tag:HA
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, non-suppressible by Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF has eye phenotype, non-suppressible by lncRNA:HsrωRNAi.Sym.UAS, Scer\GAL4GMR.PF
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU is an enhancer of adult brain phenotype of MarfUAS.cDa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU is an enhancer of mitochondrion phenotype of MarfUAS.cDa, Scer\GAL4elav.PU
Scer\GAL4ninaE.PU/Hsap\MAPTR406W.UAS is a non-enhancer of lipid droplet | adult stage | increased number phenotype of ND-42ninaE.GD6220
Scer\GAL4ninaE.PU/Hsap\MAPTR406W.UAS is a non-enhancer of ommatidium | adult stage phenotype of ND-42ninaE.GD6220
Scer\GAL454C/Hsap\MAPTR406W.UAS is a suppressor of lipid droplet | increased number | adult stage phenotype of ND-42ninaE.GD6220
Scer\GAL454C/Hsap\MAPTR406W.UAS is a suppressor of ommatidium | adult stage phenotype of ND-42ninaE.GD6220
Scer\GAL4ninaE.PU/Hsap\MAPTR406W.UAS is a non-suppressor of lipid droplet | increased number | adult stage phenotype of ND-42ninaE.GD6220
Scer\GAL4ninaE.PU/Hsap\MAPTR406W.UAS is a non-suppressor of ommatidium | adult stage phenotype of ND-42ninaE.GD6220
Scer\GAL4elav.PU/Hsap\MAPTR406W.UAS is a non-suppressor of adult brain phenotype of milt92
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU is a non-suppressor of mitochondrion phenotype of Scer\GAL4elav.PU, milt92
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU is a non-suppressor of adult brain phenotype of GelUAS.cDa, Scer\GAL4elav.PU
Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU is a non-suppressor of mitochondrion phenotype of GelUAS.cDa, Scer\GAL4elav.PU
DCTN1-p150GD1455, Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has axon | larval stage phenotype
DCTN2-p50GD13758, Hsap\MAPTR406W.UAS, Scer\GAL4elav-C155 has axon | larval stage phenotype
Co-expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav-C155 and Hsap\SNCANcra\QUAS.cOa under the control of Ncra\QFQF2.nSyb induces lethality.
DCTN2-p50 silencing (DCTN2-p50GD13758, Scer\GAL4elav-C155) in combination with Hsap\MAPTR406W.Scer\UAS expression does not result in any obvious changes to the microtubule network in larval segmental nerves.
Scer\GAL4elav-C155-mediated expression of Hsap\MAPTR406W.Scer\UAS in combination with silencing of DCTN1-p150 (DCTN1-p150GD1455) or DCTN2-p50 (DCTN2-p50GD13758) results in axonal swellings in larval segmental nerves.
Scer\GAL4elav-C155-mediated co-expression of Hsap\MAPTR406W.Scer\UAS and DCTN2-p50GD13758 has no apparent effect on larval motor coordination or locomotion.
Scer\GAL4elav-C155-mediated co-expression of Hsap\MAPTR406W.Scer\UAS with DCTN1-p150GD1455 or DCTN2-p50GD13758 strongly reduces eclosion rates.
Scer\GAL4D42-mediated co-expression of Hsap\MAPTR406W.Scer\UAS with DCTN2-p50GD13758 has no impact on viability but an age-dependent decline in locomotion skills is observed.
Co-expression of Hsap\SOD1A4V.Scer\UAS enhances the toxicity of Scer\GAL4GMR.PU>Hsap\MAPTR406W.Scer\UAS in Drosophila compound eyes. The rough eye phenotype caused by Hsap\MAPTR406W.Scer\UAS-expression becomes more severe, and the ommatidia are more severely fused and irregular.
Co-expression of Hsap\SOD1Scer\UAS.cWa enhances the toxicity of Scer\GAL4GMR.PU>Hsap\MAPTR406W.Scer\UAS in Drosophila compound eyes. The rough eye phenotype caused by Hsap\MAPTR406W.Scer\UAS-expression becomes more severe, and the ommatidia are more severely fused and irregular.
Co-expression of Hsap\SOD1Scer\UAS.cWa shortens the lifespan of files expressing Scer\GAL4elav.PU>Hsap\MAPTR406W.Scer\UAS and exacerbates their movement impairment.
Co-expression of Hsap\SOD1A4V.Scer\UAS shortens the lifespan of files expressing Scer\GAL4elav.PU>Hsap\MAPTR406W.Scer\UAS and exacerbates their movement impairment.
Co-expression of Hsap\SOD1Scer\UAS.cWa exacerbates the brain damage caused by the expression of Scer\GAL4elav.PU>Hsap\MAPTR406W.Scer\UAS. The number of vacuoles is significantly increased in the double-transgenic flies compared with Hsap\MAPTR406W.Scer\UAS-expression alone.
Co-expression of Hsap\SOD1A4V.Scer\UAS exacerbates the brain damage caused by the expression of Scer\GAL4elav.PU>Hsap\MAPTR406W.Scer\UAS. The number of vacuoles is significantly increased in the double-transgenic flies compared with Hsap\MAPTR406W.Scer\UAS-expression alone.
The decreased lifespan resulting from the expression of Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PU is suppressed by POLDIP2EY08866.
Co-expression of Scer\GAL4elav.PU>AGO3HMS00125 suppresses the Scer\GAL4elav.PU>Hsap\MAPTR406W.Scer\UAS-induced neuronal apoptosis.
Co-expression of Scer\GAL4elav.PU>AGO3GL00117 suppresses the Scer\GAL4elav.PU>Hsap\MAPTR406W.Scer\UAS-induced neuronal apoptosis and locomotory defects.
Heterozygous Su(var)3-92 enhances the Scer\GAL4elav.PU>Hsap\MAPTR406W.Scer\UAS induced neuronal apoptosis and locomotory defects.
Heterozygous Su(var)3-91 enhances the Scer\GAL4elav.PU>Hsap\MAPTR406W.Scer\UAS induced neuronal apoptosis.
Heterozygous Su(var)205MB11439 enhances the Scer\GAL4elav.PU>Hsap\MAPTR406W.Scer\UAS induced neuronal apoptosis.
Heterozygous Su(var)2055 enhances the Scer\GAL4elav.PU>Hsap\MAPTR406W.Scer\UAS induced neuronal apoptosis and locomotory defects.
Co-expression of Scer\GAL4elav.PU>E(bx)JF01709 suppresses the Scer\GAL4elav.PU>Hsap\MAPTR406W.Scer\UAS-induced neuronal apoptosis and locomotory defects.
Co-expression of Scer\GAL4elav.PU>Nurf-38JF01299 suppresses the Scer\GAL4elav.PU>Hsap\MAPTR406W.Scer\UAS-induced neuronal apoptosis.
Heterozygous ash1B1 suppresses the Scer\GAL4elav.PU>Hsap\MAPTR406W.Scer\UAS-induced neuronal apoptosis.
Co-expression of Scer\GAL4elav.PU>ash1dsRNA.Scer\UAS.cUa suppresses the Scer\GAL4elav.PU>Hsap\MAPTR406W.Scer\UAS-induced neuronal apoptosis and locomotory defects.
Expression of ZnT63CScer\UAS.cWa partially suppresses the rough eye phenotype seen in flies expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PU. Lifespan is also increased. The number of brain vacuoles in reduced.
Expression of Zip42C.1dsRNA.Scer\UAS partially suppresses the rough eye phenotype seen in flies expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PU. Lifespan is also increased. The number of brain vacuoles in reduced.
Expression of ZnT63CdsRNA.Scer\UAS.cWa enhances the rough eye phenotype seen in flies expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PU. Lifespan is also further shortened. The level of vacuolisation in the CNS is exacerbated.
Expression of Zip42C.1Scer\UAS.cLa enhances the rough eye phenotype seen in flies expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PU. Lifespan is also further shortened. The level of vacuolisation in the CNS is exacerbated.
p5311-1B-1 enhances the neurodegeneration phenotype induced by expression of Scer\GAL4elav.PLu>Hsap\MAPTR406W.Scer\UAS.
p535A-1-4 enhances the neurodegeneration phenotype induced by expression of Scer\GAL4elav.PLu>Hsap\MAPTR406W.Scer\UAS.
One copy of Nmnatunspecified significantly impairs the learning and memory abilities of two day old flies expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PU.
Expression of NmnatScer\UAS.cZa suppresses the learning and memory deficits seen in 20 day old flies expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PU. The climbing defects are also suppressed to near wild type levels. The brain vacuolisation seen at 20 days post eclosion is almost completely suppressed and fewer apoptotic cells are seen in the midbrain.
Expression of NmnatWR.Scer\UAS suppresses the learning and memory deficits seen in 20 day old flies expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PU. The climbing defects are also suppressed. The brain vacuolisation seen at 20 days post eclosion is almost completely suppressed and fewer apoptotic cells are seen in the midbrain.
milt92 has no effect on the mitochondrial elongation defect seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4elav.PU, however, as in milt92 single mutants, the overall number of mitochondria is increased, with an elevated number of both elongated and normal mitochondria.
Expression of Drp1Scer\UAS.cDb significantly suppresses the increase in mitochondria length seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4elav.PU. The increases in neurotoxicity and cell cycle activation are also significantly rescued.
Expression of MarfJF01650 significantly suppresses the increase in mitochondria length seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4elav.PU. The increases in neurotoxicity and cell cycle activation are also significantly rescued.
The increase in mitochondria length seen when either MarfScer\UAS.cDa or Hsap\MAPTR406W.Scer\UAS are expressed under the control of Scer\GAL4elav.PU is enhanced when the two constructs are co-expressed. Increased levels of neurodegeneration and cell cycle activation are also seen.
Expression of Drp1GD10456 enhances the increase in mitochondria length seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4elav.PU. Increased levels of neurodegeneration and cell cycle activation are also seen.
Expression of opa1-likes3475 significantly suppresses the increase in mitochondria length seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4elav.PU. The increased neurotoxicity is also significantly rescued.
Drp1T26 enhances the increase in mitochondria length seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4elav.PU. Increased levels of neurotoxicity are also seen.
Df(1)Exel6239 significantly suppresses the increase in mitochondria length seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4elav.PU. The increase in neurotoxicity is also significantly rescued.
Expression of Drp1Scer\UAS.cDb suppresses the increase in superoxide production seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4elav.PU.
Expression of MarfJF01650 suppresses the increase in superoxide production seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4elav.PU.
Expression of MarfScer\UAS.cDa enhances the increase in superoxide production seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4elav.PU.
Expression of Drp1GD10456 enhances the increase in superoxide production seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4elav.PU.
Expression of Drp1T:Zzzz\FLAG,T:Zzzz\TC,T:Ivir\HA1 has no effect on the increase in mitochondria length or neurotoxicity seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4elav.PU.
Expression of WASpScer\UAS.cBa enhances the increase in mitochondria length seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4elav.PU.
Expression of f+t13 enhances the increase in mitochondria length seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4elav.PU.
Expression of GelScer\UAS.cDa significantly suppresses the increase in mitochondria length seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4elav.PU, with the rescue flies having a mitochondrial length similar to expression of GelScer\UAS.cDa alone. The increases in neurotoxicity and superoxide production are also significantly rescued.
One copy of zip1 enhances the increase in mitochondria length seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4elav.PU.
One copy of sqhAX3 enhances the increase in mitochondria length seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4elav.PU.
Klc8ex94/+ enhances the partial lethality induced by the expression of Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4Appl.G1a.
A cathD1 homozygous background further reduces the lifespan of Hsap\MAPTR406W.Scer\UAS (Scer\GAL4elav-C155) flies by almost 50%.
Flies expressing Hsap\MAPTR406W.Scer\UAS neuronally (under the control of Scer\GAL4elav-C155) in a cathD1 null background exhibit an almost 3-fold increase in apoptotic cell death (as visualized with TUNEL). A similar effect is seen on neurodegeneration, with an increase in vacuolar degeneration in aged double mutant flies.
A heterozygous Xbp1k13803 background significantly increases the level of apoptosis mediated by expression of Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav-C155.
Co-expression of Xbp1GD4745 with Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav-C155 significantly increases the level of cell death seen in the nervous system.
Co-expression of Hsap\MAPTR406W.Scer\UAS with Vha100-1GD12710 in developing eyes exposed to two days of intense light stimulation accelerates the degenerative photoreceptor phenotype.
Trxr-1Δ1/+ or Sod2n283/+ enhances the neurodegeneration of the cortex and neuropil seen in adult brains expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PU, as evidenced by increased vacuolization and neuron apoptosis in these regions.
Co-expression of PHGPxScer\UAS.cMa or Sod2Scer\UAS.cMa partially suppresses the neuron apoptosis in the cortex and neuropil of adult brains expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PU.
Expression of tsrScer\UAS.T:Zzzz\His6 in animals expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PLu suppresses neuronal cell death.
Expression of Act5CScer\UAS.T:Avic\GFP in animals expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PLu enhances neuronal cell death.
Expression of Hsap\APP695.T.Scer\UAS enhances the rough eye phenotype seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4GMR.PF.
Expression of lkb1Scer\UAS.cWa enhances the eye phenotypes seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4GMR.PF, resulting in severe disorganisation of the eye and drastic loss of photoreceptor neurons and surrounding cells.
Eye degeneration due to expression of Hsap\MAPTR406W.Scer\UAS in the eye (under the control of Scer\GAL4GMR.PF) is enhanced in a loqsf00791 background.
Co-expression of dapScer\UAS.cdNa and RbfScer\UAS.cDa in adult brains expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PLu significantly reduces the number of dying cells observed. Vacuolar degeneration of the lamina is rescued in these animals.
Co-expression of dapScer\UAS.cdNa and cdc2E51Q.Scer\UAS in adult brains expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PLu significantly reduces the number of dying cells observed.
Expression of CycAScer\UAS.cWa in adult brains expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PLu significantly increases the number of dying cells observed. Vacuolar degeneration of the lamina is enhanced in these animals.
Expression of CycDScer\UAS.cMa in adult brains expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PLu results in semi-lethality.
Expression of gigΔAkt-P.Scer\UAS.T:Zzzz\FLAG in adult brains expressing Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4elav.PLu suppresses increased cell death.
Co-expression of a weak par-1Scer\UAS.cSa expression line enhances the eye phenotype caused by expression of Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4hs.2sev, resulting in smaller eyes. A 15% loss in photoreceptor neurons is seen in these flies. Co-expression of par-1Scer\UAS.cSa and Hsap\MAPTR406W.Scer\UAS under the control of Scer\GAL4Cha.7.4 results in profound vacuole formation in the cell bodies and neuronal processes of the cholinergic neurons.